Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-Kesimpta-ofatumumab-data-show-long-term-preservation-of-IgG-IgM-levels-and-no-increas-35665506/?utm_source=whatsapp&utm_medium=social&utm_campaign=share